SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Anne M. Pesenacker, Adele Y. Wang, Amrit Singh, Jana Gillies, Youngwoong Kim, Ciriaco A. Piccirillo, Duc Nguyen, W. Nicholas Haining, Scott J. Tebbutt, Constadina Panagiotopoulos, Megan K. Levings, A Regulatory T-Cell Gene Signature Is a Specific and Sensitive Biomarker to Identify Children With New-Onset Type 1 Diabetes, Diabetes, 2016, 65, 4, 1031

    CrossRef

  2. 2
    S. Hamari, T. Kirveskoski, V. Glumoff, P. Kulmala, O. Simell, M. Knip, R. Veijola, Analyses of regulatory CD4+CD25+FOXP3+ T cells and observations from peripheral T cell subpopulation markers during the development of type 1 diabetes in children, Scandinavian Journal of Immunology, 2016, 83, 4
  3. 3
    L. S. K. Walker, M. von Herrath, CD4 T cell differentiation in type 1 diabetes, Clinical & Experimental Immunology, 2016, 183, 1
  4. 4
    Remi J. Creusot, Manuela Battaglia, Maria-Grazia Roncarolo, C. Garrison Fathman, Concise Review: Cell-Based Therapies and Other Non-Traditional Approaches for Type 1 Diabetes, STEM CELLS, 2016, 34, 4
  5. 5
    Leilei Zhou, Tianyi Cao, Yufeng Wang, Hui Yao, Guanhuan Du, Guangjie Chen, Xiaoyin Niu, Guoyao Tang, Frequently Increased but Functionally Impaired CD4+CD25+ Regulatory T Cells in Patients with Oral Lichen Planus, Inflammation, 2016,

    CrossRef

  6. 6
    Nadir Askenasy, Mechanisms of autoimmunity in the non-obese diabetic mouse: effector/regulatory cell equilibrium during peak inflammation, Immunology, 2016, 147, 4
  7. 7
    Jane H. Buckner, Gerald T. Nepom, Obstacles and opportunities for targeting the effector T cell response in type 1 diabetes, Journal of Autoimmunity, 2016,

    CrossRef

  8. 8
    Mario R. Ehlers, Strategies for clinical trials in type 1 diabetes, Journal of Autoimmunity, 2016,

    CrossRef

  9. 9
    Iria Gomez-Tourino, Sefina Arif, Martin Eichmann, Mark Peakman, T cells in type 1 diabetes: Instructors, regulators and effectors: A comprehensive review, Journal of Autoimmunity, 2016, 66, 7

    CrossRef

  10. 10
    Roberto González-Amaro, Mónica Marazuela, T regulatory (Treg) and T helper 17 (Th17) lymphocytes in thyroid autoimmunity, Endocrine, 2016, 52, 1, 30

    CrossRef

  11. 11
    Gerlies Treiber, Barbara Prietl, Elke Fröhlich-Reiterer, Evelyne Lechner, Anja Ribitsch, Maria Fritsch, Birgit Rami-Merhar, Claudia Steigleder-Schweiger, Winfried Graninger, Martin Borkenstein, Thomas R. Pieber, Cholecalciferol supplementation improves suppressive capacity of regulatory T-cells in young patients with new-onset type 1 diabetes mellitus — A randomized clinical trial, Clinical Immunology, 2015, 161, 2, 217

    CrossRef

  12. 12
    Valentina Perri, Benedetta Russo, Antonino Crinò, Riccardo Schiaffini, Ezio Giorda, Marco Cappa, Maria Rosado, Alessandra Fierabracci, Expression of PD-1 Molecule on Regulatory T Lymphocytes in Patients with Insulin-Dependent Diabetes Mellitus, International Journal of Molecular Sciences, 2015, 16, 9, 22584

    CrossRef

  13. 13
    K. Åkesson, A. Tompa, A. Rydén, M. Faresjö, Low expression of CD39+/CD45RA+ on regulatory T cells (Treg) cells in type 1 diabetic children in contrast to high expression of CD101+/CD129+ on Treg cells in children with coeliac disease, Clinical & Experimental Immunology, 2015, 180, 1
  14. 14
    Jennie H.M. Yang, Antony J. Cutler, Ricardo C. Ferreira, James L. Reading, Nicholas J. Cooper, Chris Wallace, Pamela Clarke, Deborah J. Smyth, Christopher S. Boyce, Guo-Jian Gao, John A. Todd, Linda S. Wicker, Timothy I.M. Tree, Natural Variation in Interleukin-2 Sensitivity Influences Regulatory T-Cell Frequency and Function in Individuals With Long-standing Type 1 Diabetes, Diabetes, 2015, 64, 11, 3891

    CrossRef

  15. 15
    Charlotte R. Grant, Rodrigo Liberal, Giorgina Mieli-Vergani, Diego Vergani, Maria Serena Longhi, Regulatory T-cells in autoimmune diseases: Challenges, controversies and—yet—unanswered questions, Autoimmunity Reviews, 2015, 14, 2, 105

    CrossRef

  16. 16
    Basset ElEssawy, Xian C. Li, Type 1 diabetes and T regulatory cells, Pharmacological Research, 2015, 98, 22

    CrossRef

  17. 17
    Vitalijs Ovcinnikovs, Lucy S.K. Walker, Regulatory T Cells in Health and Disease, 2015,

    CrossRef

  18. 18
    Tingting Tan, Yufei Xiang, Christopher Chang, Zhiguang Zhou, Alteration of Regulatory T Cells in Type 1 Diabetes Mellitus: A Comprehensive Review, Clinical Reviews in Allergy & Immunology, 2014, 47, 2, 234

    CrossRef

  19. 19
    Angeline Gradolatto, Dani Nazzal, Frédérique Truffault, Jacky Bismuth, Elie Fadel, Maria Foti, Sonia Berrih-Aknin, Both Treg cells and Tconv cells are defective in the Myasthenia gravis thymus: Roles of IL-17 and TNF-α, Journal of Autoimmunity, 2014, 52, 53

    CrossRef

  20. 20
    Gamal Allam, Adnan A. Alsulaimani, Hamed Alghamdi, Hameed Alswat, Burhan M. Edrees, Iftikhar Ahmad, Amre Nasr, Changes in the Levels of Cytokines in Both Diabetic/Non-Diabetic Type I Children Living in a Moderate Altitude Area in Saudi Arabia, High Altitude Medicine & Biology, 2014, 15, 3, 380

    CrossRef

  21. 21
    Khalid Bin Dhuban, Mara Kornete, Edward S. Mason, Ciriaco A. Piccirillo, Functional dynamics of Foxp3+ regulatory T cells in mice and humans, Immunological Reviews, 2014, 259, 1
  22. 22
    Kesley Attridge, Lucy S. K. Walker, Homeostasis and function of regulatory T cells (Tregs) in vivo: lessons from TCR-transgenic Tregs, Immunological Reviews, 2014, 259, 1
  23. 23
    Bart O. Roep, Timothy I. M. Tree, Immune modulation in humans: implications for type 1 diabetes mellitus, Nature Reviews Endocrinology, 2014, 10, 4, 229

    CrossRef

  24. 24
    A. Ferraro, A. M. D'Alise, T. Raj, N. Asinovski, R. Phillips, A. Ergun, J. M. Replogle, A. Bernier, L. Laffel, B. E. Stranger, P. L. De Jager, D. Mathis, C. Benoist, Interindividual variation in human T regulatory cells, Proceedings of the National Academy of Sciences, 2014, 111, 12, E1111

    CrossRef

  25. 25
    Monika Ryba-Stanisławowska, Karolina Rybarczyk-Kapturska, Agnieszka Brandt, Małgorzata Myśliwiec, Jolanta Myśliwska, IVS1 −397T>C Estrogen Receptor α Polymorphism Is Associated with Low-Grade Systemic Inflammatory Response in Type 1 Diabetic Girls, Mediators of Inflammation, 2014, 2014, 1

    CrossRef

  26. 26
    Kate S. Smigiel, Shivani Srivastava, J. Michael Stolley, Daniel J. Campbell, Regulatory T-cell homeostasis: steady-state maintenance and modulation during inflammation, Immunological Reviews, 2014, 259, 1
  27. 27
    F. Haseda, A. Imagawa, Y. Murase-Mishiba, J. Terasaki, T. Hanafusa, CD4+CD45RAFoxP3high activated regulatory T cells are functionally impaired and related to residual insulin-secreting capacity in patients with type 1 diabetes, Clinical & Experimental Immunology, 2013, 173, 2
  28. 28
    Natalia Marek-Trzonkowska, Małgorzata Myśliwec, Janusz Siebert, Piotr Trzonkowski, Clinical application of regulatory T cells in type 1 diabetes, Pediatric Diabetes, 2013, 14, 5
  29. 29
    S. Ceeraz, C. Hall, E. H. Choy, J. Spencer, V. M. Corrigall, Defective CD8+CD28 regulatory T cell suppressor function in rheumatoid arthritis is restored by tumour necrosis factor inhibitor therapy, Clinical & Experimental Immunology, 2013, 174, 1
  30. 30
    M. Peakman, Immunological pathways to β-cell damage in Type 1 diabetes, Diabetic Medicine, 2013, 30, 2
  31. 31
    A. Schneider, S. A. Long, K. Cerosaletti, C. T. Ni, P. Samuels, M. Kita, J. H. Buckner, In Active Relapsing-Remitting Multiple Sclerosis, Effector T Cell Resistance to Adaptive Tregs Involves IL-6-Mediated Signaling, Science Translational Medicine, 2013, 5, 170, 170ra15

    CrossRef

  32. 32
    Linda Åkerman, Johnny Ludvigsson, Rosaura Casas, Low C-peptide levels and decreased expression of TNF and CD45 in children with high risk of type 1 diabetes, Clinical Immunology, 2013, 148, 1, 4

    CrossRef

  33. 33
    Wenhao Chen, Aini Xie, Lawrence Chan, Mechanistic basis of immunotherapies for type 1 diabetes mellitus, Translational Research, 2013, 161, 4, 217

    CrossRef

  34. 34
    M. Pihl, L. Åkerman, S. Axelsson, M. Chéramy, M. Hjorth, R. Mallone, J. Ludvigsson, R. Casas, Regulatory T cell phenotype and function 4 years after GAD–alum treatment in children with type 1 diabetes, Clinical & Experimental Immunology, 2013, 172, 3
  35. 35
    A. Kaas, C. Pfleger, A. V. Kharagjitsingh, N. C. Schloot, L. Hansen, K. Buschard, B. P. C. Koeleman, B. O. Roep, H. B. Mortensen, B. Z. Alizadeh, Association between age, IL-10, IFNγ, stimulated C-peptide and disease progression in children with newly diagnosed Type 1 diabetes, Diabetic Medicine, 2012, 29, 6
  36. 36
    Georgina S. Thorborn, Laura Pomeroy, Heidi Ishohanni, Barry S. Peters, Annapurna Vyakarnam, Elevated effector cell sensitivity to Treg-cell suppression that is not associated with reduced Th17-cell expression distinguishes HIV+ asymptomatic subjects from progressors, European Journal of Immunology, 2012, 42, 1
  37. 37
    Norio Kanatsuna, George K. Papadopoulos, Antonis K. Moustakas, Åke Lenmark, Etiopathogenesis of Insulin Autoimmunity, Anatomy Research International, 2012, 2012, 1

    CrossRef

  38. 38
    C.-R. Li, B. J. G. Baaten, L. M. Bradley, Harnessing memory adaptive regulatory T cells to control autoimmunity in type 1 diabetes, Journal of Molecular Cell Biology, 2012, 4, 1, 38

    CrossRef

  39. 39
    J. Matthis, G. T. Nepom, T Cell Autoreactivity in the Transplant Milieu, American Journal of Transplantation, 2012, 12, 7
  40. 40
    Ellen J. Wehrens, Berent J. Prakken, Femke van Wijk, T cells out of control—impaired immune regulation in the inflamed joint, Nature Reviews Rheumatology, 2012, 9, 1, 34

    CrossRef

  41. 41
    Linda Schober, Diana Radnai, Edgar Schmitt, Karsten Mahnke, Christof Sohn, Andrea Steinborn, Term and preterm labor: decreased suppressive activity and changes in composition of the regulatory T-cell pool, Immunology and Cell Biology, 2012, 90, 10, 935

    CrossRef

  42. 42
    Jocea MR Michels-van Amelsfort, Gina J Walter, Leonie S Taams, CD4+CD25+regulatory T cells in systemic sclerosis and other rheumatic diseases, Expert Review of Clinical Immunology, 2011, 7, 4, 499

    CrossRef

  43. 43
    A. Ferraro, C. Socci, A. Stabilini, A. Valle, P. Monti, L. Piemonti, R. Nano, S. Olek, P. Maffi, M. Scavini, A. Secchi, C. Staudacher, E. Bonifacio, M. Battaglia, Expansion of Th17 Cells and Functional Defects in T Regulatory Cells Are Key Features of the Pancreatic Lymph Nodes in Patients With Type 1 Diabetes, Diabetes, 2011, 60, 11, 2903

    CrossRef

  44. 44
    Manuela Battaglia, Maria-Grazia Roncarolo, Immune intervention with T regulatory cells: Past lessons and future perspectives for type 1 diabetes, Seminars in Immunology, 2011, 23, 3, 182

    CrossRef

  45. 45
    N. Bangsgaard, K. Engkilde, T. Menné, M. Løvendorf, G. K. Jacobsen, J. Olsen, L. Skov, Impaired hapten sensitization in patients with autoimmune disease, Clinical & Experimental Immunology, 2011, 165, 3
  46. 46
    Mikael Pihl, Mikael Chéramy, Jenny Mjösberg, Johnny Ludvigsson, Rosaura Casas, Increased expression of regulatory T cell-associated markers in recent-onset diabetic children, Open Journal of Immunology, 2011, 01, 03, 57

    CrossRef

  47. 47
    Cai-Xia Tu, Wan-Wan Jin, Mao Lin, Zhao-Hui Wang, Mao-Qiang Man, Levels of TGF-β1 in serum and culture supernatants of CD4+CD25+ T cells from patients with non-segmental vitiligo, Archives of Dermatological Research, 2011, 303, 9, 685

    CrossRef

  48. 48
    S. Arif, F. Moore, K. Marks, T. Bouckenooghe, C. M. Dayan, R. Planas, M. Vives-Pi, J. Powrie, T. Tree, P. Marchetti, G. C. Huang, E. N. Gurzov, R. Pujol-Borrell, D. L. Eizirik, M. Peakman, Peripheral and Islet Interleukin-17 Pathway Activation Characterizes Human Autoimmune Diabetes and Promotes Cytokine-Mediated  -Cell Death, Diabetes, 2011, 60, 8, 2112

    CrossRef

  49. 49
    Jessica Herrath, Malin Müller, Petra Amoudruz, Peter Janson, Jakob Michaëlsson, Per T. Larsson, Christina Trollmo, Sukanya Raghavan, Vivianne Malmström, The inflammatory milieu in the rheumatic joint reduces regulatory T-cell function, European Journal of Immunology, 2011, 41, 8
  50. 50
    Aziz Alami Chentoufi, Simon Gaudreau, Alex Nguyen, Mahmoud Sabha, Abdelaziz Amrani, Geyhad ElGhazali, Type I Diabetes-Associated Tolerogenic Properties of Interleukin-2, Clinical and Developmental Immunology, 2011, 2011, 1

    CrossRef

  51. 51
    A. Hughson, I. Bromberg, B. Johnson, S. Quataert, N. Jospe, D. J. Fowell, Uncoupling of Proliferation and Cytokines From Suppression Within the CD4+CD25+Foxp3+ T-Cell Compartment in the 1st Year of Human Type 1 Diabetes, Diabetes, 2011, 60, 8, 2125

    CrossRef

  52. 52
    M. Peakman, M. von Herrath, Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential, Diabetes, 2010, 59, 9, 2087

    CrossRef

  53. 53
    John A. Todd, Etiology of Type 1 Diabetes, Immunity, 2010, 32, 4, 457

    CrossRef

  54. 54
    Gregory L Cvetanovich, David A Hafler, Human regulatory T cells in autoimmune diseases, Current Opinion in Immunology, 2010, 22, 6, 753

    CrossRef

  55. 55
    Jane Hoyt Buckner, Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases, Nature Reviews Immunology, 2010, 10, 12, 849

    CrossRef

  56. 56
    Anette-G. Ziegler, Gerald T. Nepom, Prediction and Pathogenesis in Type 1 Diabetes, Immunity, 2010, 32, 4, 468

    CrossRef

  57. 57
    Bart O. Roep, Mark Peakman, Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes, Nature Reviews Immunology, 2010, 10, 2, 145

    CrossRef

  58. 58
    R. A. O'Connor, L. S. Taams, S. M. Anderton, Translational Mini-Review Series on Th17 Cells: CD4+ T helper cells: functional plasticity and differential sensitivity to regulatory T cell-mediated regulation, Clinical & Experimental Immunology, 2010, 159, 2
  59. 59
    Nicola Gagliani, Alessandra Ferraro, Maria Grazia Roncarolo, Manuela Battaglia, Autoimmune diabetic patients undergoing allogeneic islet transplantation: are we ready for a regulatory T-cell therapy?, Immunology Letters, 2009, 127, 1, 1

    CrossRef

  60. 60
    Wendy Gaisford, Anne Cooke, Can infections protect against autoimmunity?, Current Opinion in Rheumatology, 2009, 21, 4, 391

    CrossRef

  61. 61
    Liqing Wang, Edwin F. de Zoeten, Mark I. Greene, Wayne W. Hancock, Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3+ regulatory T cells, Nature Reviews Drug Discovery, 2009,

    CrossRef

  62. 62
    Creg J. Workman, Andrea L. Szymczak-Workman, Lauren W. Collison, Meenu R. Pillai, Dario A. A. Vignali, The development and function of regulatory T cells, Cellular and Molecular Life Sciences, 2009, 66, 16, 2603

    CrossRef

  63. 63
    Gui-xing Jiang, Yun-fu Cui, Xiang-yu Zhong, Sheng Tai, Wei Liu, Zhi-dong Wang, Yu-guang Shi, Use of a Cocktail Regimen Consisting of Soluble Galectin-1, Rapamycin and Histone Deacetylase Inhibitor May Effectively Prevent Type 1 Diabetes, Archives of Medical Research, 2009, 40, 5, 424

    CrossRef

  64. 64
    Virginia Litwin, James Andahazy, Monitoring the Cellular Components of the Immune System During Clinical Trials: A Translational Medicine Approach,